ENGITIX LTD

HQ - London

Summary

Engitix Therapeutics is a biotech company developing therapies that target the extracellular matrix to treat cancer and fibrosis.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 19 M

Avg. Deal Size£ 19 M

Market Context

Senior Management